Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: An RCT

European Journal of Clinical Nutrition

Volumn 66, Issue 3, 2012, Pages 399-404

  Van Der Meij, B S ^a   Langius, J A E ^a   Spreeuwenberg, M D ^a   Slootmaker, S M ^a   Paul, M A ^a   Smit, E F ^a   Van Leeuwen, P A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

eicosapenaenoic acid; lung neoplasms; n 3 fatty acids; quality of life; RCT

Indexed keywords

ANTINEOPLASTIC AGENT; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEHYDRATION; DEPRESSION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG FEVER; FEMALE; FUNCTIONAL STATUS; GRIP STRENGTH; HEALTH STATUS; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; MALAISE; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PNEUMOTHORAX; PROTEIN INTAKE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; THROMBOSIS; VOMITING;

ACTIVITIES OF DAILY LIVING; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COGNITION; COMBINED MODALITY THERAPY; DIETARY PROTEINS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FEMALE; HAND STRENGTH; HEALTH STATUS; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASM STAGING; PHYSICAL FITNESS; QUALITY OF LIFE;

EID: 84858038464     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.214     Document Type: Article

References (40)

1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83, 584-594. (Pubitemid 351720831)
2. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89, 225S-233S. (Pubitemid 16138265)
3. Price KA, Azzoli CG, Gaspar LE. Chemoradiation for unresectable stage III nonsmall cell lung cancer. Semin Thorac Cardiovasc Surg 2008; 20, 204-209.
4. De Leyn P, Vansteenkiste J, Lievens Y, Van RD, Nafteux P, Decker G et al. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer. J Thorac Oncol 2009; 4, 62-68.
5. van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007; 99, 442-450. (Pubitemid 47073567)
6. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90, 1905-1911. (Pubitemid 38746329)
7. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy. Oral Oncol 1999; 35, 27-32. (Pubitemid 28546841)
8. Ravasco P, Monteiro-Grillo I, Marques VP, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005; 27, 659-668. (Pubitemid 41113766)
9. Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 2011; 23, 322-330.
10. Barber MD. The pathophysiology and treatment of cancer cachexia. Nutr Clin Prac 2002; 17, 203-209.
11. Bennani-Baiti N, Davis MP. Cytokines and cancer anorexia cachexia syndrome. Am J Hosp Palliat Care 2008; 25, 407-411.
12. Jho DH, Cole SM, Lee EM, Espat NJ. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 2004; 3, 98-111.
13. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007; 77, 327-335. (Pubitemid 350198856)
14. Guarcello M, Riso S, Buosi R, D'Andrea F. EPA-enriched oral nutritional suport in patients with lung cancer: effects on nutritional status and quality of life. Nutr Ther Metab 2007; 25, 25-30. (Pubitemid 351954703)
15. Bayram I, Erbey F, Celik N, Nelson JL, Tanyeli A. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children. Pediatr Blood Cancer 2009; 52, 571-574.
16. Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004; 90, 996-1002. (Pubitemid 38495818)
17. Fearon KC, von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52, 1479-1486. (Pubitemid 37176729)
18. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 2006; 24, 3401-3407. (Pubitemid 46638896)
19. Meij van der BS, Langius JAE, Smit EF, Spreeuwenberg MD, von Blomberg BM, Heijboer AC et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 2010; 140, 1774-1780.
20. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85, 365-376. (Pubitemid 23073154)
21. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Nat Rev Cancer 1980; 45, 2220-2224. (Pubitemid 10150440)
22. Karnofsky DA, Burchenal JH. Evaluation of chemotherapeutic agents. In: MacLeod CM (ed). The Clinical Evaluation of Chemotherapeutic Agents in Cancer. Columbia University Press: New York, 1949, p 196.
23. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985; 66, 69-74. (Pubitemid 15134048)
24. Slootmaker SM, Chinapaw M, Schuit AJ, van Mechelen W, Koppes LL. Concurrent validity of the PAM accelerometer relative to the MTI Actigraph using oxygen consumption as a reference. Scand J Med Sci Sports 2009; 19, 36-43.
25. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32, S498-S504.
26. Twisk JW, Kemper HC, Mellenbergh GJ, van Mechelen W, Post GB. Relation between the longitudinal development of lipoprotein levels and lifestyle parameters during adolescence and young adulthood. Ann Epidemiol 1996; 6, 246-256. (Pubitemid 26163151)
27. Twisk JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004; 19, 769-776. (Pubitemid 41184428)
28. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42, 121-130.
29. Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) 1997; 92, 215-221.
30. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 2000; 98, 389-399. (Pubitemid 30197852)
31. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr 1999; 129, 1120-1125. (Pubitemid 29250159)
32. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000; 36, 177-184. (Pubitemid 30437038)
33. Ravasco P, Monteiro-Grillo I, Camilo ME. Does nutrition influence quality of life in cancer patients undergoing radiotherapy? Radiother Oncol 2003; 67, 213-220. (Pubitemid 36695100)
34. Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA. Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 2006; 59, 704-709. (Pubitemid 43825726)
35. Isenring E, Bauer J, Capra S. The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 2003; 57, 305-309. (Pubitemid 36240484)
36. Carlson SE. Early determinants of development: a lipid perspective. Am J Clin Nutr 2009; 89, 1523S-1529S.
37. Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ et al. Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiol Biomarkers Prev 2009; 18, 664-672.
38. Lowe SS, Watanabe SM, Baracos VE, Courneya KS. Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey. J Pain Symptom Manage 2009; 38, 785-796.
39. Gibney E, Elia M, Jebb SA, Murgatroyd P, Jennings G. Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 1997; 46, 1412-1417. (Pubitemid 28053205)
40. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold M, on behalf of the EORTC Quality of Life Study Group. The EORTC QLQ-C30 Scoring Manual, 2nd edn. European Organization for Research and Treatment of Cancer: Brussels, 1999.